UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in TNGX — Tango Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in TNGX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,583,999
+$1,216,726 QoQ
Shares Held
75,717
+82.7% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
15 quarters on record
Voting authority
Sole 31.457928866701007.ToString("F0")%
Shared 0.ToString("F0")%
None 68.542071133299.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. TNGX ranks #112 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in TNGX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,583,999 | 75,717 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $367,273 | 41,453 | Shares | Defined | 2026-02-13 | |
| 2024-12-31 | $236,542 | 76,551 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $579,824 | 75,302 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $675,434 | 78,722 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $96,868 | 12,200 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $120,780 | 12,200 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $137,372 | 12,200 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $109,550 | 32,997 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $130,338 | 32,997 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $88,450 | 12,200 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $44,164 | 12,200 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $55,266 | 12,200 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $92,476 | 12,200 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $133,468 | 12,200 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||